GL1X · GenesisL1 explorer

Research workbench

Crystal structure of cisplatin bound to a plasmodium falciparum glutaredoxin 1 (PfGrx1)

Analyse Crystal structure of cisplatin bound to a plasmodium falciparum glutaredoxin 1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4N0Z
Type
protein
Length
107 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.7
Source
Plasmodium falciparum
Molecule
Glutaredoxin
EC
1.20.4.1
UniProt
Q9NLB2
Ligands
CPT

Structure

x-ray diffraction · resolution 1.7 · 1 distinct chain · 53% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlutaredoxin (EC 1.20.4.1)protein10753% helix, 17% strandQ9NLB2

Ligands and binding sites

  • CPT · Cisplatin · ligand · chains A
  • MPO · 3[N-morpholino]propane sulfonic acid · additive · chains A
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 4N0Z · Crystal structure of cisplatin bound to a plasmodium falciparum glutaredoxin 1 (PFGRX1) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.